Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromsø Study 1979-2016

BMJ Open

Volumn 7, Issue 8, 2017, Pages

  Hopstock, Laila Arnesdatter ^a   Bønaa, Kaare Harald ^a,b,c   Eggen, Anne Elise ^a   Grimsgaard, Sameline ^a   Jacobsen, Bjarne K ^a   Løchen, Maja Lisa ^a,d   Mathiesen, Ellisiv B ^a,d   Njølstad, Inger ^a   Wilsgaard, Tom ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

anticholesterolemic agents; cholesterol; cohort studies; epidemiology; lipids; longitudinal studies

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DRUG USE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORWEGIAN (CITIZEN); POPULATION RESEARCH; REVIEW; SEX DIFFERENCE; TOTAL CHOLESTEROL LEVEL; TREND STUDY; AGE DISTRIBUTION; BLOOD; LIFESTYLE; NORWAY; RISK FACTOR; SEX RATIO; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; LIFE STYLE; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NORWAY; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 85046991700     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-015001     Document Type: Review

References (40)

1. Piepoli MF, Hoes A, Agewall S, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016;2016:2315-81.
2. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014;2:634-47.
3. Mannsverk J, Wilsgaard T, Mathiesen EB, et al. Trends in modifiable risk factors are associated with declining incidence of hospitalized and nonhospitalized acute coronary heart disease in a population. Circulation 2016;133:74-81.
4. Björck L, Rosengren A, Bennett K, et al. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009;30:1046-56.
5. Laatikainen T, Critchley J, Vartiainen E, et al. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005;162:764-73.
6. Aspelund T, Gudnason V, Magnusdottir BT, et al. Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One 2010;5:e13957.
7. Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet 2011;377:578-86.
8. Johansson I, Nilsson LM, Stegmayr B, et al. Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden. Nutr J 2012;11:40.
9. Borodulin K, Vartiainen E, Peltonen M, et al. Forty-year trends in cardiovascular risk factors in Finland. Eur J Public Health 2015;25:539-46.
10. Jacobsen BK, Eggen AE, Mathiesen EB, et al. Cohort profile: the Tromso Study. Int J Epidemiol 2012;41:961-7.
11. Nielsen MW, Søndergaard B, Kjøller M, et al. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. J Clin Epidemiol 2008;61:919-24.
12. Silverman BW. Density estimation for statistics and data analysis. New York: Chapman & Hall, 1986.
13. Thorsson B, Steingrimsdottir L, Halldorsdottir S, et al. Changes in total cholesterol levels in Western societies are not related to statin, but rather dietary factors: the example of the Icelandic population. Eur Heart J 2013;34:1778-82.
14. Eliasson M, Janlert U, Jansson JH, et al. Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The Northern Sweden MONICA study. J Intern Med 2006;260:551-9.
15. Cífková R, Skodová Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis 2010;211:676-81.
16. Ford ES, Capewell S. Trends in total and low-density lipoprotein cholesterol among U.S. adults: contributions of changes in dietary fat intake and use of cholesterol-lowering medications. PLoS One 2013;8:e65228.
17. Arnett DK, Jacobs DR, Luepker RV, et al. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 2005;112:3884-91.
18. Weijenberg MP, Feskens EJ, Kromhout D. Age-related changes in total and high-density-lipoprotein cholesterol in elderly Dutch men. Am J Public Health 1996;86:798-803.
19. Hershcopf RJ, Elahi D, Andres R, et al. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. J Chronic Dis 1982;35:101-14.
20. Abbott RD, Sharp DS, Burchfiel CM, et al. Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the honolulu heart program. Ann Epidemiol 1997;7:417-24.
21. Strand BH, Tverdal A. Trends in educational inequalities in cardiovascular risk factors: a longitudinal study among 48,000 middle-aged Norwegian men and women. Eur J Epidemiol 2006;21:731-9.
22. Upmeier E, Lavonius S, Heinonen P, et al. Longitudinal changes in serum lipids in older people the Turku elderly study 1991-2006. Age Ageing 2011;40:280-3.
23. Szklo M, Chambless LE, Folsom AR, et al. Trends in plasma cholesterol levels in the Atherosclerosis Risk In Communities (ARIC) study. Prev Med 2000;30:252-9.
24. Anderson KM, Wilson PW, Garrison RJ, et al. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis 1987;68:59-66.
25. Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 1997;96:37-43.
26. Yamada M, Wong FL, Kodama K, et al. Longitudinal trends in total serum cholesterol levels in a Japanese cohort, 1958-1986. J Clin Epidemiol 1997;50:425-34.
27. Wilson PW, Anderson KM, Harris T, et al. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 1994;49:M252-M257.
28. Tu YK, Davey Smith G, Gilthorpe MS. A new approach to age-periodcohort analysis using partial least squares regression: the trend in blood pressure in the Glasgow alumni cohort. PLoS One 2011;6:e19401.
29. Mindell JS, Giampaoli S, Goesswald A, et al. HES Response Rate Group. Sample selection, recruitment and participation rates in health examination surveys in Europe - experience from seven national surveys. BMC Med Res Methodol 2015;15:1-19.
30. Jacobsen BK, Njølstad I, Thune I, et al. Increase in weight in all birth cohorts in a general population: The Tromsø Study, 1974-1994. Arch Int Med 2001;161:466-72.
31. Jacobsen BK, Aars NA. Changes in body mass index and the prevalence of obesity during 1994-2008: repeated cross-sectional surveys and longitudinal analyses. The Tromsø Study. BMJ Open 2015;5:e007859.
32. Eggen AE, Mathiesen EB, Wilsgaard T, et al. Trends in cardiovascular risk factors across levels of education in a general population: is the educational gap increasing? The Tromsø study 1994-2008. J Epidemiol Community Health 2014;68:712-9.
33. Morseth B. Time trends in physical activity in the Tromsø Study, Northern Norway. Int J Epidemiol 2015;44(suppl-1):i150.
34. The Tromsø Study. 2015 www. tromsoundersokelsen. no (accessed 1 Jan 2016).
35. The Norwegian Directorate of Health. Norwegian dietary trends 2014. 2014. Report No: IS-2255 https://helsedirektoratet. no/Lists/Publikasjoner/Attachments/802/Utviklingen- i- norsk- kosthold- 2014-IS- 2255. pdf (accessed 1 Jan 2016).
36. Valsta LM, Tapanainen H, Sundvall J, et al. Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr 2010;13(6A):932-8.
37. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39.
38. Vangen-Lønne AM, Wilsgaard T, Johnsen SH, et al. Time trends in incidence and case fatality of ischemic stroke: the Tromsø Study 1977-2010. Stroke 2015;46:1173-9.
39. Mannsverk J, Wilsgaard T, Njølstad I, et al. Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study. Eur J Prev Cardiol 2012;19:927-34.
40. Hopstock LA, Bønaa KH, Eggen AE, et al. Longitudinal and secular trends in blood pressure among women and men in birth cohorts born between 1905 and 1977: The Tromsø Study 1979 to 2008. Hypertension 2015;66:496-501.